Wall Street analysts expect that Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) will post sales of $43.80 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Biohaven Pharmaceutical’s earnings. Biohaven Pharmaceutical posted sales of $1.15 million during the same quarter last year, which indicates a positive year over year […]